Novel therapies for hemophilia A – the role of the von Willebrand factor chaperone
Author(s): ,
Sonia Aguila
Affiliations:
Haemostasis Research Group, Department of Molecular and Cellular Therapeutics, Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, Dublin, Ireland
James S. O'Donnell
Affiliations:
Haemostasis Research Group, Department of Molecular and Cellular Therapeutics, Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, Dublin, Ireland. National Coagulation Centre, St James's Hospital, Dublin, Ireland
Correspondence: James O'Donnell, Irish Centre for Vascular Biology, Royal College of Surgeons in Ireland, Ardilaun House, 111 St Stephen's Green, Dublin 2, Ireland|Tel.: +3531 402 2209|E‐mail: jamesodonnell@rcsi.ie
ISTH Academy. O'Donnell J. Mar 1, 2019; 273405
James O'Donnell
James O'Donnell
Login now to access Regular content available to all registered users.

Access to Premium content is currently a membership benefit.

Click here to join ISTH or renew your membership.

You may also access ISTH content "anytime, anywhere" with the FREE ISTH Academy App for iOS and Android.
Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies